Filing Details

Accession Number:
0000899243-22-034702
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-01 17:22:23
Reporting Period:
2022-10-28
Accepted Time:
2022-11-01 17:22:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831868 Seastar Medical Holding Corp ICU Surgical & Medical Instruments & Apparatus (3841) 853681132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1951900 Trust Plan Pension Employees' Dow Sylvia Stoesser Center
2211 H.h. Dow Way
Midland MI 48674
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-10-28 4,149,841 $0.00 4,149,841 No 4 A Direct
Common Stock Acquisiton 2022-10-28 300,000 $0.00 4,449,841 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (Right to Buy) Acquisiton 2022-10-28 1,726 $0.00 1,726 $10.00
Common Stock Warrants (Right to Buy) Acquisiton 2022-10-28 300,000 $0.00 300,000 $11.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,726 2025-06-20 No 4 A Direct
300,000 2027-10-28 No 4 P Direct
Footnotes
  1. On October 28, 2022, LMF Acquisition Opportunities, Inc., a Delaware corporation ("LMF"), consummated a business combination (the "Business Combination") by and among LMF, LMF Merger Sub, Inc., a Delaware corporation and directly wholly-owned subsidiary of LMF ("Merger Sub") and SeaStar Medical, Inc., a Delaware corporation ("SeaStar Medical"), pursuant to which SeaStar Medical merged with and into Merger Sub, with SeaStar Medical continuing as the surviving entity in the merger as a wholly-owned subsidiary of LMF, and with LMF changing its name to SeaStar Medical Holding Corporation ("SeaStar Medical Holdings"). As part of the Business Combination each share of SeaStar Medical stock was exchanged for 1.20321 shares of common stock of SeaStar Medical Holdings ("Common Stock").
  2. In a concurrent private placement in connection with the Business Combination, the Reporting Person acquired 300,000 shares of Common Stock and warrants to purchase 300,000 shares of Common Stock for an aggregate purchase price of $3,000,000.
  3. The warrants are fully exercisable.
  4. As part of the Business Combination, each SeaStar Medical warrant was exchanged for a warrant to purchase 1.20321 shares of Common Stock.
  5. The warrants are fully exercisable